|
|
|
Insider
Information: |
Rhodes Jason P |
Relationship: |
Director |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
138,000 |
|
Indirect Shares
|
23,308,240 |
|
|
Direct
Value |
$202,860 |
|
|
Indirect Value
|
$420,842,579 |
|
|
Total
Shares |
23,446,240 |
|
|
Total
Value |
$421,045,439 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
0
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
Percentage
Gain/Loss : |
-2.2%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Epizyme, Inc. |
EPZM |
President, CFO and Tre... |
2014-09-22 |
138,000 |
2014-01-06 |
0 |
Premium* |
|
Replimune Group Inc |
REPL |
Director |
2018-07-24 |
0 |
2021-01-26 |
3,228,912 |
Premium* |
|
Generation Bio Co. |
GBIO |
Director |
|
0 |
2021-09-29 |
8,279,484 |
Premium* |
|
Dyne Therapeutics, Inc. |
DYN |
|
|
0 |
2024-03-01 |
6,545,479 |
Premium* |
|
Disc Medicine, Inc |
IRON |
Director |
|
0 |
2021-02-05 |
5,254,365 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
62 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
DYN |
Dyne Therapeutics, Inc. |
|
|
2024-02-15 |
4 |
AS |
$23.88 |
$4,249,600 |
I/I |
(177,906) |
7,148,211 |
0 |
% |
|
DYN |
Dyne Therapeutics, Inc. |
|
|
2024-02-16 |
4 |
AS |
$23.14 |
$3,765,040 |
I/I |
(162,707) |
6,985,504 |
0 |
% |
|
DYN |
Dyne Therapeutics, Inc. |
|
|
2024-02-20 |
4 |
AS |
$22.71 |
$3,852,653 |
I/I |
(169,539) |
6,815,965 |
0 |
% |
|
DYN |
Dyne Therapeutics, Inc. |
|
|
2024-02-21 |
4 |
AS |
$22.44 |
$4,164,817 |
I/I |
(184,501) |
6,631,464 |
0 |
% |
|
DYN |
Dyne Therapeutics, Inc. |
|
|
2024-02-22 |
4 |
AS |
$22.66 |
$2,704,698 |
I/I |
(119,360) |
6,512,104 |
0 |
% |
|
DYN |
Dyne Therapeutics, Inc. |
|
|
2024-02-23 |
4 |
AS |
$22.70 |
$4,470,266 |
I/I |
(196,928) |
920,843 |
0 |
% |
|
DYN |
Dyne Therapeutics, Inc. |
|
|
2024-02-26 |
4 |
AS |
$23.59 |
$5,886,673 |
I/I |
(248,219) |
903,527 |
0 |
% |
|
DYN |
Dyne Therapeutics, Inc. |
|
|
2024-02-27 |
4 |
AS |
$24.38 |
$8,998,426 |
I/I |
(368,699) |
877,806 |
0 |
% |
|
DYN |
Dyne Therapeutics, Inc. |
|
|
2024-02-28 |
4 |
AS |
$24.83 |
$4,741,804 |
I/I |
(190,920) |
864,487 |
0 |
% |
|
DYN |
Dyne Therapeutics, Inc. |
|
|
2024-03-01 |
4 |
AS |
$30.05 |
$1,398,347 |
I/I |
(46,534) |
847,388 |
0 |
% |
|
REPL |
Replimune Group Inc |
Director |
|
2018-07-24 |
4 |
A |
$0.00 |
$0 |
I/I |
4,453,386 |
4,453,386 |
0 |
- |
|
REPL |
Replimune Group Inc |
Director |
|
2019-11-18 |
4 |
B |
$13.61 |
$14,971,000 |
I/I |
1,100,000 |
1,100,000 |
2.1 |
- |
|
GBIO |
Generation Bio Co. |
Director |
|
2020-06-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,590,726 |
|
- |
|
GBIO |
Generation Bio Co. |
Director |
|
2020-06-16 |
4 |
A |
$0.00 |
$0 |
I/I |
10,040,032 |
12,630,758 |
0 |
- |
|
DYN |
Dyne Therapeutics, Inc. |
Director |
|
2020-09-16 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,110,404 |
|
- |
|
DYN |
Dyne Therapeutics, Inc. |
Director |
|
2020-09-21 |
4 |
A |
$0.00 |
$0 |
I/I |
7,638,511 |
1,608,785 |
0 |
- |
|
REPL |
Replimune Group Inc |
Director |
|
2020-12-07 |
4 |
AS |
$45.45 |
$3,120,459 |
I/I |
(67,890) |
35,709 |
0 |
% |
|
REPL |
Replimune Group Inc |
Director |
|
2020-12-08 |
4 |
AS |
$46.02 |
$5,056,591 |
I/I |
(108,256) |
32,234 |
0 |
% |
|
REPL |
Replimune Group Inc |
Director |
|
2020-12-09 |
4 |
AS |
$42.51 |
$1,804,182 |
I/I |
(41,216) |
29,748 |
0 |
% |
|
REPL |
Replimune Group Inc |
Director |
|
2020-12-10 |
4 |
AS |
$42.68 |
$1,484,083 |
I/I |
(34,391) |
27,669 |
0 |
% |
|
REPL |
Replimune Group Inc |
Director |
|
2020-12-11 |
4 |
AS |
$43.32 |
$1,372,512 |
I/I |
(31,636) |
25,757 |
0 |
% |
|
REPL |
Replimune Group Inc |
Director |
|
2020-12-14 |
4 |
AS |
$42.69 |
$1,637,847 |
I/I |
(37,659) |
23,481 |
0 |
% |
|
REPL |
Replimune Group Inc |
Director |
|
2020-12-15 |
4 |
AS |
$42.40 |
$1,731,253 |
I/I |
(40,819) |
21,013 |
0 |
% |
|
REPL |
Replimune Group Inc |
Director |
|
2020-12-16 |
4 |
AS |
$42.13 |
$533,998 |
I/I |
(12,675) |
20,247 |
0 |
% |
|
REPL |
Replimune Group Inc |
Director |
|
2020-12-17 |
4 |
AS |
$42.00 |
$484,470 |
I/I |
(11,535) |
19,550 |
0 |
% |
|
62 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|